This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Biotech

Grading Sobek's Mid-Year Biotech Stock Predictions

Grading Sobek's Mid-Year Biotech Stock Predictions

The year is halfway over, so it's a good time to look back and give mid-term grades on my fearless 2014 predictions.

07/09/14 - 10:14 AM EDT

AbbVie Lifts Shire Bid to $51.6 Billion As It Seeks Tax Inversion

Drugmaker AbbVie is raising its takeover offer for Irish pharmaceutical company Shire for a fourth time as it attempts to secure a tax inversion deal.

07/09/14 - 10:07 AM EDT

Grading Sobek's Mid-Year Biotech Stock Predictions

Grading Sobek's Mid-Year Biotech Stock Predictions

The year is halfway over, so it's a good time to look back and give mid-term grades on my fearless 2014 predictions.

07/09/14 - 10:14 AM EDT

AbbVie Lifts Shire Bid to $51.6 Billion As It Seeks Tax Inversion

Drugmaker AbbVie is raising its takeover offer for Irish pharmaceutical company Shire for a fourth time as it attempts to secure a tax inversion deal.

07/09/14 - 10:07 AM EDT

Radient Pharma: RIP

Radient Pharma: RIP

  • Tickers in this article:
  • RXPC

The SEC halts trading in Radient Pharmaceuticals.

07/08/14 - 09:52 AM EDT

Provectus Admits Cash Running Low, Financing Coming Soon

Provectus Admits Cash Running Low, Financing Coming Soon

  • Tickers in this article:
  • PVCT

Provectus Biopharmaceuticals issued a "CEO Letter" Tuesday regurgitating all the recent spin and ridiculously unrealistic talking points about the company's experimental (but already obsolete) melanoma therapy PV-10.

07/08/14 - 09:14 AM EDT

Sarepta's Monday Selloff on New (Old) Worries Addressed

Sarepta's Monday Selloff on New (Old) Worries Addressed

  • Tickers in this article:
  • SRPT
  • RNA

Sarepta is selling off Monday on new worries about eteplirsen efficacy. Of course, these are really just old worries, recycled.

07/07/14 - 02:49 PM EDT

Why Genetic Technologies (GENE) Stock Is Spiking Today

Why Genetic Technologies (GENE) Stock Is Spiking Today

  • Tickers in this article:
  • GENE

Gene Technologies (GENE) shares are climbing after reporting a rise in sales of its cheek swab breast caner test, BREVAGen.

07/07/14 - 02:31 PM EDT

Merger Talk: Public Taste Shift Could Enable Lorillard Deal

  • Tickers in this article:
  • LO
  • RAI

With shares trading at a premium right now -- up about 45% over the last 12 months -- there is talk that Reynolds American could acquire Lorillard.

07/07/14 - 09:35 AM EDT

Arena CEO Dumps Stock as Share Price, Investor Confidence Slide

Arena CEO Dumps Stock as Share Price, Investor Confidence Slide

  • Tickers in this article:
  • ARNA

Lief's $1.3 million sale of Arena shares was disclosed in an SEC filing last week.

07/07/14 - 11:23 AM EDT

Why Cooper Companies (COO) Stock Is Falling Today

Why Cooper Companies (COO) Stock Is Falling Today

  • Tickers in this article:
  • COO

Cooper Companies (COO) shares are falling after Standard & Poor's lowered its 'BBB' credit rating to 'negative'.

07/03/14 - 10:31 AM EDT

Why Regado Biosciences (RGDO) Stock Is Plummeting Today

Why Regado Biosciences (RGDO) Stock Is Plummeting Today

  • Tickers in this article:
  • RGDO

Regado Biosciences (RGDO) shares are falling after the Data Safety Monitoring Board shut down its REGULATE-PCI drug trials.

07/03/14 - 11:36 AM EDT

Why BIND Therapeutics (BIND) Stock Is Falling In After-Hours Trading Today

Why BIND Therapeutics (BIND) Stock Is Falling In After-Hours Trading Today

BIND Therapeutics (BIND) shares are tanking after announcing that it was not pursuing a collaboration with Amgen (AMGN).

07/02/14 - 05:10 PM EDT

Why Intrexon (XON) Stock Is Gaining Today

Why Intrexon (XON) Stock Is Gaining Today

  • Tickers in this article:
  • XON

Intrexon (XON) shares are climbing after the company purchased Trans Ova Genetics.

07/02/14 - 01:31 PM EDT

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
DOW 16,985.61 +78.99 0.47%
S&P 500 1,972.83 +9.12 0.46%
NASDAQ 4,419.0340 +27.5710 0.63%

Brokerage Partners

Advertising Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs